Drug Therapy Limited in Patients with Huntington’s Disease

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 1999年 / 14卷 / 12期
关键词：
Clozapine; Atypical Antipsychotic; Selegiline; Riluzole; Tetrabenazine;
D O I：
10.2165/00042310-199914120-00002
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 7
页数：2
相关论文
共 50 条
  • [1] Therapy in Huntington's Disease: Where Are We?
    Nance, Martha A.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (04) : 359 - 366
  • [2] Therapy in Huntington’s Disease: Where Are We?
    Martha A. Nance
    Current Neurology and Neuroscience Reports, 2012, 12 : 359 - 366
  • [3] Riluzole therapy in Huntington's disease (HD)
    Rosas, HD
    Koroshetz, WJ
    Jenkins, BG
    Chen, YI
    Hayden, DL
    Beal, MF
    Cudkowicz, ME
    MOVEMENT DISORDERS, 1999, 14 (02) : 326 - 330
  • [4] Huntington's disease: a clinical review
    Raymund AC Roos
    Orphanet Journal of Rare Diseases, 5
  • [5] Huntington’s disease
    Barbara A. Haskins
    Madaline B. Harrison
    Current Treatment Options in Neurology, 2000, 2 (3) : 243 - 262
  • [6] Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
    Frank, Samuel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 657 - 665
  • [7] Treatment of Huntington’s Disease
    Samuel Frank
    Neurotherapeutics, 2014, 11 : 153 - 160
  • [8] Therapeutics in Huntington’s Disease
    Annie Killoran
    Kevin M. Biglan
    Current Treatment Options in Neurology, 2012, 14 : 137 - 149
  • [9] Update on huntington’s disease
    Sarah B. Berman
    J. Timothy Greenamyre
    Current Neurology and Neuroscience Reports, 2006, 6 : 281 - 286
  • [10] Therapeutics in Huntington's Disease
    Killoran, Annie
    Biglan, Kevin M.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (02) : 137 - 149
12345